Destination
Does Nurix Therapeutics (NRIX) Have the Potential to Rally 85.84% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 85.8% in Nurix Therapeutics (NRIX). While the effectiveness of this hig [...]

Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

venturebeat
How Anthropic's Claude cuts SOC investigation time from 5 hours to 7 minutes

Integrating AI models directly into extended detection and response (XDR) platforms is delivering breakthrough improvements in SOC investigation speed and accuracy.In an exclusive interview with Ventu [...]

Match Score: 67.99

qz
Wall Street Analysts Predict an 113.34% Upside in Avalo Therapeutics (AVTX): Here's What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 113.3% in Avalo Therapeutics (AVTX). While the effectiveness of this hi [...]

Match Score: 58.81

qz
Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?

The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts [...]

Match Score: 57.18

Destination
Elon Musk is reportedly trying to take SpaceX public

Elon Musk is reportedly looking to finally take SpaceX public after years of resistance, according to sources who spoke to The Wall Street Journal. The company has long said it wouldn't choose a [...]

Match Score: 53.42

Destination
Does Omeros (OMER) Have the Potential to Rally 266.67% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 266.7% in Omeros (OMER). While the effectiveness of this highly sought- [...]

Match Score: 50.75

Destination
Does SM Energy (SM) Have the Potential to Rally 27.89% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 27.9% in SM Energy (SM). While the effectiveness of this highly sought- [...]

Match Score: 50.75

Destination
Does Extreme Networks (EXTR) Have the Potential to Rally 32.39% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 32.4% in Extreme Networks (EXTR). While the effectiveness of this highl [...]

Match Score: 50.75

thenextweb
Cambridge biotech STORM Therapeutics raises $56M

STC-15 is the world’s first RNA-modifying enzyme inhibitor to reach human trials. Phase 1 showed durable tumour regression across multiple sarcoma subtypes. The $56M Series C is backed entirely by e [...]

Match Score: 49.97

venturebeat
Anthropic rolls out Claude AI for finance, integrates with Excel to rival Microsoft Copilot

Anthropic is making its most aggressive push yet into the trillion-dollar financial services industry, unveiling a suite of tools that embed its Claude AI assistant directly into Microsoft Excel and c [...]

Match Score: 47.46